Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-04-01 01:54 |
Amendment No. 1 to annual report on Form 20-F for the fiscal year ended 31.12.…
|
English | 42.7 KB | ||
| 2020-03-25 11:52 |
Schedule 13G filing with the SEC by Armistice Capital, LLC
|
English | 1.5 MB | ||
| 2020-03-25 11:52 |
Schedule 13G filing with the SEC by Armistice Capital, LLC
|
English | 38.2 KB | ||
| 2020-03-24 16:45 |
Annual report for 2019 on form 20F
|
English | 1.3 MB | ||
| 2020-03-24 16:45 |
Annual report for 2019 on form 20F
|
English | 38.5 KB | ||
| 2020-03-21 20:58 |
Schedule 13G filing with the SEC by CVI Investments, Inc.
|
English | 129.1 KB | ||
| 2020-03-21 20:58 |
Schedule 13G filing with the SEC by CVI Investments, Inc.
|
English | 38.2 KB | ||
| 2020-03-17 14:59 |
6k:Kitov Closes $6.0 Million Public Offering
|
English | 125.6 KB | ||
| 2020-03-17 14:59 |
6k:Kitov Closes $6.0 Million Public Offering
|
English | 38.1 KB | ||
| 2020-03-16 14:33 |
PROSPECTUS Filed pursuant to Rule 424(b)(4) Registration No. 333-235729
|
English | 576.9 KB | ||
| 2020-03-16 14:33 |
PROSPECTUS Filed pursuant to Rule 424(b)(4) Registration No. 333-235729
|
English | 38.7 KB | ||
| 2020-03-12 15:30 |
Press Release: Kitov Pharma Provides Update on Planned U.S. Launch of ConsensiT…
|
English | 321.0 KB | ||
| 2020-03-12 15:30 |
Press Release: Kitov Pharma Provides Update on Planned U.S. Launch of ConsensiT…
|
English | 38.2 KB | ||
| 2020-03-12 15:11 |
Kitov Announces Pricing of $6.0 Million Public Offering
|
English | 165.1 KB | ||
| 2020-03-12 15:11 |
Kitov Announces Pricing of $6.0 Million Public Offering
|
English | 38.1 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
